Asia-Pacific Transfection Market, By Type (Transient Transfection, Stable Transfection), Methods (Non-Viral Methods, Viral Methods), CRISPR Transfection Methods (Non-Viral Methods, Viral Methods), Products (Reagent & Kits, Instrument, Software), Organism (Mammalian Cells, Plants, Fungi, Virus, Bacteria), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), Others), Application (In Vitro Application, In Vivo Application, Bioproduction, Others), Stage (Research, Preclinical, Clinical Phases, Commercial), End User (Biopharma, Contract Research Organizations (CROs), Contract Manufacturing Organization/ Contract Development and Manufacturing Organization (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, Others), Distribution Channel (Direct Tender, Retail Sales, Others), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2028
Market Analysis and Insights : Asia-Pacific Transfection Market
The transfection market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 11.5% in the forecast period of 2021 to 2028 and is expected to reach USD 309.85 million by 2028. Large-scale transfections used in clinical research and utilization of biopharmaceuticals in the production of proteins are the major drivers which propelled the demand of the transfection market in the forecast period.
The transfection method is used to introduce RNA, DNA or protein products in cells to alter the phenotype and genotype of the organism. Transfection method involves the new gene transfer or transferring a gene construct such as clustered regularly interspaced short palindromic repeats (CRISPR) for genome editing purposes. Transfection has wide applications in the field of immunotherapy, gene therapy and cell therapy among others. Transfection involves both non-viral and viral mediated transfection. The chemical and physical methods can achieve non – viral transfection.
The rise in the prevalence of chronic disease is acting as a driver for the transfection market growth. The high cost of instruments acts as restraint for the transfection market growth. The exploration of emerging markets is acting as an opportunity for the transfection market growth. The long approval procedure acts as challenge for the transfection market growth.
The transfection market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the transfection market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Transfection Market Scope and Market Size
The transfection market is segmented on the basis of the type, methods, CRISPR transfection methods, products, organism, types of molecule, application, stage, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the transfection market is segmented into transient transfection and stable transfection. In 2021, transient transfection segment is dominating as this method obtains transfection results in 3-7 days with high transfection efficiency rates.
- On the basis of methods, the transfection market is segmented into non-viral methods and viral methods. In 2021, non-viral methods segment is dominating in all types of transfection including CRISPR (clustered regularly interspaced short palindromic repeats) transfection as these methods provides with the high transfection efficiency and overcomes the chances of infections induces by viral transfection methods.
- On the basis of CRISPR transfection methods, the transfection market is segmented into non-viral methods and viral methods. In 2021, non-viral methods segment is dominating for CRISPR (clustered regularly interspaced short palindromic repeats) transfection as it offers allows efficient delivery of CRISPR sequences to targeted cell lines.
- On the basis of products, the transfection market is segmented into reagents & kits, instrument and software. In 2021, reagent & kits segment is dominating as these are used for enhancing the efficacy of transfection process in various genetic experiments.
- On the basis of organism, the transfection market is segmented into mammalian cells, plants, fungi, virus and bacteria. In 2021, mammalian cells segment is dominating as mammalian cells are widely used for production of monoclonal antibodies, proteins, urokinase, follicle stimulating hormone and other products as compared to other types of cells lines.
- On the basis of types of molecule, the transfection market is segmented into plasmid DNA, small interfering RNA (siRNA), proteins, DNA oligonucleotides, ribonucleoprotein complexes (RNPs) and others. In 2021, plasmid DNA segment is dominating as large number of transfection technologies have initially been developed for transfer of plasmid DNA into cells.
- On the basis of application, the transfection market is segmented into in vitro application, in vivo application, bioproduction and others. In 2021, in vitro application segment is dominating as it provides with the delivery of cargo nucleic acid molecules into cultured cells which has a crucial role in research as well as for commercial production of molecules.
- On the basis of stage, the transfection market is segmented into research, preclinical, clinical phases and commercial. In 2021, research segment is dominating due to increasing demand for gene expression across synthetic biology industry and other applications.
- On the basis of end user, the transfection market is segmented into biopharma, contract research organizations (CROs), contract manufacturing organization/contract development and manufacturing organization (CMOs/CDMOs), academia, hospitals, clinical labs and others. In 2021, biopharma segment hold the largest market share because of the increasing demand to improve efficiency & speed for production of desired cell lines.
- On the basis of distribution channel, the transfection market is segmented into direct tender, retail sales and others. In 2021, direct tender segment is dominating as it is the primary source of procurement across different end users.
Asia-Pacific Transfection Market Country Level Analysis
The transfection market is analyzed and market size information is provided on the basis of country, type, methods, CRISPR transfection methods, products, organism, types of molecule, application, stage, end user and distribution channel as referenced above.
The countries covered in the Asia-Pacific transfection market report are the Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Philippines and rest of Asia-Pacific.
Transient transfection segment in Asia-Pacific region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of utilization of biopharmaceuticals in the production of proteins. China is leading the growth of the Asia-Pacific transfection market and transient transfection segment is dominating in the country due to surging levels of investment and increasing demand of monoclonal antibodies. The transient transfection segment in Japan is growing in the Asia-Pacific transfection market owing to increasing demand of effective treatment for surging level of genetic disorders.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Exploration of Emerging Market and Surging Levels of Investment are boosting the Transfection Market
The transfection market also provides you with detailed market analysis for every country growth in transfection industry with transfection drugs sales, impact of advancement in the transfection technology and changes in regulatory scenarios with their support for the transfection market. The data is available for historic period 2011 to 2019.
Competitive Landscape and Transfection Market Share Analysis
The transfection market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to transfection market.
The major companies which are dealing in the Asia-Pacific transfection market report are Mirus Bio LLC, Promega Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, Lonza, MaxCyte, Inc., SBS Genetech, Cytiva, R&D Systems, Inc., Takara Bio Inc., Thermo Fisher Scientific Inc., Roche Molecular Systems, Inc. (a subsidiary of F. Hoffmann-La Roche Ltd), QIAGEN, OriGene Technologies, Inc., Twist Bioscience, Beckman Coulter, Inc. (a subsidiary of Danaher), Codexis, SignaGen Laboratories among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many product launches and agreements are also initiated by the companies’ worldwide which are also accelerating the transfection market.
For instance,
- In November 2020, Thermo Fisher Scientific Inc. collaborated with Northeastern University to strengthen the biopharmaceutical industry's innovation and capabilities and gene and cell therapies. The company is continuously engaged in manufacturing innovative and advanced reagents and techniques to deliver sensitivity and accuracy to the ongoing experiments and drug development. This collaboration thus allowed the company to drive the growth of valuable and highly efficient reagents and tools utilized in the transfection procedure.
Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market players is enhancing the company market in the transfection market which also provides the benefit for organization to improve their offering for transfection.
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Inhaltsverzeichnis
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC TRANSFECTION MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TRANSIENT TRANSFECTION OF TRANSFECTION LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 TOTAL ADDRESSABLE MARKET
4.1.1 BY METHOD/MODALITY
4.1.2 BY END USER
4.1.3 BY APPLICATION
4.1.4 BY STAGE
4.2 EARLY AND LATE STAGE CELL LINE DEVELOPMENT FOR BIOPHARMA AND VIRAL VECTOR PRODUCTION FOR GENE THERAPY
4.2.1 THE LIST OF APPROVED ANTIBODIES PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS AND LIST OF SELECTABLE MARKERS USED IN MAMMALIAN EXPRESSION VECTORS
5 REGULATORY FRAMEWORK
5.1 EUROPEAN UNION REGULATORY SCENARIO
5.2 U.S. REGULATORY SCENARIO
5.3 JAPAN REGULATORY SCENARIO
5.4 CHINA REGULATORY SCENARIO
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISE IN THE PREVALENCE OF CHRONIC DISEASES
6.1.2 DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS
6.1.3 GROWING DEMAND OF CHIMERIC GENES
6.1.4 LARGE-SCALE TRANSFECTIONS USED IN CLINICAL RESEARCH
6.1.5 UTILIZATION OF BIOPHARMACEUTICALS IN THE PRODUCTION OF PROTEINS
6.2 RESTRAINTS
6.2.1 HIGH COST OF TRANSFECTION PRODUCTS
6.2.2 SELECTIVE EFFECTIVENESS OF TRANSFECTION REAGENTS
6.2.3 CELL DAMAGE INDUCED BY TRANSFECTION PROCEDURE
6.3 OPPORTUNITIES
6.3.1 EXPLORATION OF EMERGING MARKET
6.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
6.3.3 INCREASING GOVERNMENT SUPPORT
6.3.4 SURGING LEVEL OF INVESTMENT
6.4 CHALLENGES
6.4.1 LONG APPROVAL PROCEDURE
6.4.2 LACK OF SAFETY LEVEL LAB FOR VIRUS ASSOCIATED TRANSFECTION
6.4.3 LACK OF TRAINED PROFESSIONALS
7 COVID-19 IMPACT OF ASIA-PACIFIC TRANSFECTION MARKET IN HEALTHCARE INDUSTRY
7.1 OVERVIEW
7.2 IMPACT ON THE PRICE
7.3 IMPACT ON DEMAND
7.4 IMPACT ON SUPPLY CHAIN
7.5 STRATEGIC INITIATIVE BY MANUFACTURERS
7.6 CONCLUSION
8 ASIA-PACIFIC TRANSFECTION MARKET, BY TYPE
8.1 OVERVIEW
8.2 TRANSIENT TRANSFECTION
8.2.1 BY STAGE
8.2.1.1 RESEARCH
8.2.1.2 PRECLINICAL
8.2.1.3 CLINICAL PHASES
8.2.1.4 COMMERCIAL
8.2.2 BY PRODUCT
8.2.2.1 REAGENT & KITS
8.2.2.2 INSTRUMENTS
8.2.2.3 SOFTWARE
8.3 STABLE TRANSECTION
8.3.1 BY STAGE
8.3.1.1 RESEARCH
8.3.1.2 PRECLINICAL
8.3.1.3 CLINICAL PHASES
8.3.1.4 COMMERCIAL
8.3.2 BY PRODUCT
8.3.2.1 REAGENT & KITS
8.3.2.2 INSTRUMENTS
8.3.2.3 SOFTWARE
9 ASIA-PACIFIC TRANSFECTION MARKET, BY METHODS
9.1 2.1 OVERVIEW
9.2 NON- VIRAL METHODS
9.2.1 CHEMICAL
9.2.1.1 Lipofection Method
9.2.1.2 Calcium Phosphate Precipitation Method
9.2.1.3 Polyethylenimine (PEI)–DNA Condensation Method
9.2.1.4 Others
9.2.2 PHYSICAL
9.2.2.1 Electroporation
9.2.2.2 Direct Microinjection
9.2.2.3 Biolistic Particle Delivery/ Particle Bombardment
9.2.2.4 Magnetofection
9.2.2.5 Sonoporation
9.2.2.6 Others
9.3 VIRAL METHODS
9.3.1 RETROVIRUS TRANSFECTION
9.3.2 ADENOVIRUS TRANSFECTION
9.3.3 LENTIVIRUS TRANSFECTION
9.3.4 OTHERS
10 ASIA-PACIFIC TRANSFECTION MARKET, BY METHODS
10.1 OVERVIEW
10.2 NON- VIRAL METHODS
10.2.1 CHEMICAL
10.2.1.1 Lipofection Method
10.2.1.2 Calcium Phosphate Precipitation Method
10.2.1.3 Polyethylenimine (PEI)–DNA Condensation Method
10.2.1.4 Others
10.2.2 PHYSICAL
10.2.2.1 Electroporation
10.2.2.2 Direct Microinjection
10.2.2.3 Biolistic Particle Delivery/ Particle Bombardment
10.2.2.4 Magnetofection
10.2.2.5 Sonoporation
10.2.2.6 Others
10.3 VIRAL METHODS
10.3.1 RETROVIRUS TRANSFECTION
10.3.2 ADENOVIRUS TRANSFECTION
10.3.3 LENTIVIRUS TRANSFECTION
10.3.4 OTHERS
11 ASIA-PACIFIC TRANSFECTION MARKET, BY PRODUCTS
11.1 OVERVIEW
11.2 REAGENTS & KITS
11.2.1 CATIONIC LIPIDS
11.2.1.1 Liposomal Reagents
11.2.1.1.1 L-Dioleoyl Phosphatidylethanolamine (DOPE)
11.2.1.1.2 DOTAP [1,2-Dioleoyloxy-3-Trimethylammonium Propane]
11.2.1.1.3 DOTMA [N-[1(2,3-Dioleoyloxy)Propyl]-N,N,N-Trimethylammonium Chloride]
11.2.1.1.4 Others
11.2.1.2 Non-Liposomal Reagents
11.2.1.2.1 DNA Transfection Reagent
11.2.1.2.2 siRNA Transfection Reagent
11.2.1.2.3 Others
11.2.2 CATIONIC POLYMER
11.2.2.1 DEAE-Dextran
11.2.2.2 Polybrene
11.2.2.3 Polyethyleneimine
11.2.2.4 Dendrimers
11.2.2.5 Others
11.2.3 NANOPARTICLES
11.2.3.1 Systemic Intravenous Injection
11.2.3.2 Direct Intratumoral Injection
11.2.4 KITS
11.2.4.1 Transporter Transfection Reagent
11.2.4.2 GMP Transfection Reagent
11.2.4.3 Neon Electroporation
11.2.4.4 Cellfectin Ii Transfection Reagent
11.2.4.5 DMRIE-C Transfection Reagent
11.2.4.6 Lipofectamine Transfection Reagent
11.2.4.7 Lipofectin Transfection Reagent
11.2.4.8 Oligofectamine Transfection Reagent
11.2.4.9 Optifect Transfection Reagent
11.2.4.10 Cell Specific Transfection Reagent
11.2.4.11 Gene Gun Kit
11.2.4.12 Plasmid Transfection Reagent
11.2.4.13 Others
11.2.5 CUVETTE CHAMBER
11.2.6 OTHERS
11.3 INSTRUMENT
11.3.1 ELECTROPORATION SYSTEM
11.3.1.1 Neon Transfection System
11.3.1.2 Others
11.3.2 ELECTRO-CELL FUSION GENERATOR
11.3.3 ELECTRO-KINETIC TRANSFECTION SYSTEM
11.3.4 HEPTA SYSTEM
11.3.5 TUBING PREP STATION
11.3.6 RT-PCR
11.3.7 GUN SYSTEM
11.3.8 MICROPLATE READER
11.3.9 SONOPORATION SYSTEM
11.3.10 MICROSCOPES
11.3.11 OTHERS
12 ASIA-PACIFIC TRANSFECTION MARKET, BY ORGANISM
12.1 OVERVIEW
12.2 MAMMALIAN CELLS
12.3 PLANTS
12.4 FUNGI
12.5 VIRUS
12.6 BACTERIA
13 ASIA-PACIFIC TRANSFECTION MARKET, BY TYPES OF MOLECULE
13.1 OVERVIEW
13.2 PLASMID DNA
13.3 SMALL INTERFERING RNA (SIRNA)
13.4 PROTEINS
13.5 DNA OLIGONUCLEOTIDES
13.6 RIBONUCLEOPROTEIN COMPLEXES (RNPS)
13.7 OTHERS
14 ASIA-PACIFIC TRANSFECTION MARKET, BY APPLICATION
14.1 OVERVIEW
14.2 BY TYPE
14.2.1 IN VITRO APPLICATION
14.2.1.1 Gene Expression
14.2.1.2 RNA Interference
14.2.2 IN VIVO APPLICATION
14.2.2.1 Gene Therapy
14.2.2.2 Cellular-Based Therapy
14.2.3 BIOPRODUCTION
14.2.3.1 Antibody/Protein Production
14.2.3.2 Virus Production
14.2.4 OTHERS
14.3 BY INDUSTRY
14.3.1 SYNTHETIC BIOLOGY
14.3.1.1 Biopharma
14.3.1.2 Monoclonal Antibodies (mAbs)
14.3.1.3 Recombinant Proteins
14.3.1.4 Biofuels
14.3.1.5 Cell Line Development
14.3.1.6 Flavors & Fragrances
14.3.1.7 Enzyme Engineering & Production
14.3.1.8 Specialty Chemicals
14.3.2 AGRICULTURE
14.3.3 OTHERS
15 ASIA-PACIFIC TRANSFECTION MARKET, BY STAGES
15.1 OVERVIEW
15.2 RESEARCH
15.3 PRECLINICAL
15.4 CLINICAL PHASES
15.5 COMMERCIAL
16 ASIA-PACIFIC TRANSFECTION MARKET, BY END USER
16.1 OVERVIEW
16.2 BIOPHARMA
16.3 CONTRACT RESEARCH ORGANIZATIONS (CROS)
16.4 CONTRACT MANUFACTURING ORGANIZATION/ CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CMOS/CDMOS)
16.5 ACADEMIA
16.6 HOSPITALS
16.7 CLINICAL LABS
16.8 OTHERS
17 ASIA-PACIFIC TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL
17.1 OVERVIEW
17.2 DIRECT TENDERS
17.3 RETAIL SALES
17.4 OTHERS
18 ASIA-PACIFIC TRASNFECTION MARKET, BY GEOGRAPHY
18.1 ASIA PACIFIC
18.1.1 CHINA
18.1.2 JAPAN
18.1.3 INDIA
18.1.4 AUSTRALIA
18.1.5 SOUTH KOREA
18.1.6 SINGAPORE
18.1.7 THAILAND
18.1.8 MALAYSIA
18.1.9 INDONESIA
18.1.10 PHILIPPINES
18.1.11 REST OF ASIA- PACIFIC
19 ASIA-PACIFIC TRANSFECTION MARKET: COMPANY LANDSCAPE
19.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
20 SWOT ANALYSIS
21 COMPANY PROFILE
21.1 THERMOFISHER SCIENTIFIC INC.
21.1.1 COMPANY SNAPSHOT
21.1.2 REVENUE ANALYSIS
21.1.3 COMPANY SHARE ANALYSIS
21.1.4 PRODUCT PORTFOLIO
21.1.5 RECENT DEVELOPMENTS
21.2 ROCHE MOLECULAR SYSTEMS, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD)
21.2.1 COMPANY SNAPSHOT
21.2.2 REVENUE ANALYSIS
21.2.3 COMAPYN SHARE ANALYSIS
21.2.4 PRODUCT PORTFOLIO
21.2.5 RECENT DEVELOPMENTS
21.3 QIAGEN
21.3.1 COMPANY SNAPSHOT
21.3.2 REVENUE ANALYSIS
21.3.3 COMPANY SHARE ANALYSIS
21.3.4 PRODUCT PORTFOLIO
21.3.5 RECENT DEVELOPMENTS
21.4 PROMEGA CORPORATION
21.4.1 COMPANY SNAPSHOT
21.4.2 COMPANY SHARE ANALYSIS
21.4.3 PRODUCT PORTFOLIO
21.4.4 RECENT DEVELOPMENTS
21.5 TAKARA BIO INC.
21.5.1 COMPANY SNAPSHOT
21.5.2 REVENUE ANALYSIS
21.5.3 COMPANY SHARE ANALYSIS
21.5.4 PRODUCT PORTFOLIO
21.5.5 RECENT DEVELOPMENTS
21.6 BIO-RAD LABORATORIES, INC.
21.6.1 COMPANY SNAPSHOT
21.6.2 REVENUE ANANLYSIS
21.6.3 PRODUCT PORTFOLIO
21.6.4 RECENT DEVELOPMENT
21.7 LONZA
21.7.1 COMPANY SNAPSHOT
21.7.2 REVENUE ANANLYSIS
21.7.3 PRODUCT PORTFOLIO
21.7.4 RECENT DEVELOPMENTS
21.8 CYTIVA
21.8.1 COMPANY SNAPSHOT
21.8.2 PRODUCT PORTFOLIO
21.8.3 RECENT DEVELOPMENTS
21.9 ALTOGEN BIOSYSTEMS
21.9.1 COMPANY SNAPSHOT
21.9.2 PRODUCT PORTFOLIO
21.9.3 RECENT DEVELOPMENTS
21.1 AMYRIS
21.10.1 COMPANY SNAPSHOT
21.10.2 REVENUE ANALYSIS
21.10.3 PRODUCT PORTFOLIO
21.10.4 RECENT DEVELOPMENTS
21.11 APPLIED BIOLOGICAL MATERIALS INC. (ABM)
21.11.1 COMPANY SNAPSHOT
21.11.2 PRODUCT PORTFOLIO
21.11.3 RECENT DEVELOPMENT
21.12 AUTOLUS
21.12.1 COMPANY SNAPSHOT
21.12.2 PRODUCT PORTFOLIO
21.12.3 RECENT DEVELOPMENTS
21.13 AVANTI POLAR LIPIDS (A SUBSIDIARY OF CRODA INTERNATIONAL PLC)
21.13.1 COMPANY SNAPSHOT
21.13.2 REVENUE ANALYSIS
21.13.3 PRODUCT PORTFOLIO
21.13.4 RECENT DEVELOPMENT
21.14 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER)
21.14.1 COMPANY SNAPSHOT
21.14.2 REVENUE ANALYSIS
21.14.3 PRODUCT PORTFOLIO
21.14.4 RECENT DEVELOPMENTS
21.15 CODEXIS
21.15.1 COMPANY SNAPSHOT
21.15.2 REVENUE ANALYSIS
21.15.3 PRODUCT PORTFOLIO
21.15.4 RECENT DEVELOPMENTS
21.16 CONAGEN, INC.
21.16.1 COMPANY SNAPSHOT
21.16.2 PRODUCT PORTFOLIO
21.16.3 RECENT DEVELOPMENTS
21.17 FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION)
21.17.1 COMPANY SNAPSHOT
21.17.2 REVENUE ANANLYSIS
21.17.3 PRODUCT PORTFOLIO
21.17.4 RECENT DEVELOPMENT
21.18 GENLANTIS INC.
21.18.1 COMPANY SNAPSHOT
21.18.2 PRODUCT PORTFOLIO
21.18.3 RECENT DEVELOPMENTS
21.19 GENO TECHNOLOGY INC., USA
21.19.1 COMPANY SNAPSHOT
21.19.2 PRODUCT PORTFOLIO
21.19.3 RECENT DEVELOPMENTS
21.2 GINKGO BIOWORKS
21.20.1 COMPANY SNAPSHOT
21.20.2 PRODUCT PORTFOLIO
21.20.3 RECENT DEVELOPMENTS
21.21 IMPOSSIBLE FOODS INC.
21.21.1 COMPANY SNAPSHOT
21.21.2 PRODUCT PORTFOLIO
21.21.3 RECENT DEVELOPMENTS
21.22 MAXCYTE, INC.
21.22.1 COMPANY SNAPSHOT
21.22.2 REVENUE ANALYSIS
21.22.3 PRODUCT PORTFOLIO
21.22.4 RECENT DEVELOPMENTS
21.23 MERCK KGAA
21.23.1 COMPANY SNAPSHOT
21.23.2 REVENUE ANALYSIS
21.23.3 PRODUCT PORTFOLIO
21.23.4 RECENT DEVELOPMENTS
21.24 MIRUS BIO LLC.
21.24.1 COMPANY SNAPSHOT
21.24.2 PRODUCT PORTFOLIO
21.24.3 RECENT DEVELOPMENTS
21.25 ORIGENE TECHNOLOGIES, INC.
21.25.1 COMPANY SNAPSHOT
21.25.2 PRODUCT PORTFOLIO
21.25.3 RECENT DEVELOPMENTS
21.26 PERKINELMER CHEMAGEN TECHNOLOGIE GMBH (A SUBSIDIARY OF PERKINELMER INC.)
21.26.1 COMPANY SNAPSHOT
21.26.2 REVENUE ANANLYSIS
21.26.3 PRODUCT PORTFOLIO
21.26.4 RECENT DEVELOPMENTS
21.27 POLYPLUS TRANSFECTION
21.27.1 COMPANY SNAPSHOT
21.27.2 PRODUCT PORTFOLIO
21.27.3 RECENT DEVELOPMENTS
21.28 POSEIDA THERAPEUTICS, INC.
21.28.1 COMPANY SNAPSHOT
21.28.2 PRODUCT PORTFOLIO
21.28.3 RECENT DEVELOPMENTS
21.29 R&D SYSTEMS, INC.
21.29.1 COMPANY SNAPSHOT
21.29.2 PRODUCT PORTFOLIO
21.29.3 RECENT DEVELOPMENT
21.3 SBS GENETECH
21.30.1 COMPANY SNAPSHOT
21.30.2 PRODUCT PORTFOLIO
21.30.3 RECENT DEVELOPMENTS
21.31 SIGNAGEN LABORATORIES
21.31.1 COMPANY SNAPSHOT
21.31.2 PRODUCT PORTFOLIO
21.31.3 RECENT DEVELOPMENTS
21.32 TWIST BIOSCIENCE
21.32.1 COMPANY SNAPSHOT
21.32.2 REVENUE ANALYSIS
21.32.3 PRODUCT PORTFOLIO
21.32.4 RECENT DEVELOPMENTS
21.33 VERVE THERAPEUTICS, INC.
21.33.1 COMPANY SNAPSHOT
21.33.2 PRODUCT PORTFOLIO
21.33.3 RECENT DEVELOPMENTS
21.34 ZYMERGEN INC.
21.34.1 COMPANY SNAPSHOT
21.34.2 PRODUCT PORTFOLIO
21.34.3 RECENT DEVELOPMENTS
22 QUESTIONNAIRE
23 RELATED REPORTS
Tabellenverzeichnis
LIST OF TABLES
TABLE 1 LIST OF APPROVED ANTIBODIES PRODUCED IN CHO CELLS
TABLE 2 EU DIRECTIVES AND REGULATIONS RELATED TO CLINICAL TRIALS INVOLVING GTMPS
TABLE 3 GOVERNMENT ENTITIES THAT ARE IN CHARGE OF TYPE 2 USES
TABLE 4 ASIA-PACIFIC TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 5 ASIA-PACIFIC TRANSIENT TRANSFECTION IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 6 ASIA-PACIFIC TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 7 ASIA-PACIFIC TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 8 ASIA-PACIFIC STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 9 ASIA-PACIFIC STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 10 ASIA-PACIFIC TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 11 ASIA-PACIFIC NON- VIRAL METHODS IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 12 ASIA-PACIFIC NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 13 ASIA-PACIFIC CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 14 ASIA-PACIFIC PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 15 ASIA-PACIFIC VIRAL METHODS IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 16 ASIA-PACIFIC VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 17 ASIA-PACIFIC CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 18 ASIA-PACIFIC NON- VIRAL METHODS IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 19 ASIA-PACIFIC NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 20 ASIA-PACIFIC CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 21 ASIA-PACIFIC PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 22 ASIA-PACIFIC VIRAL METHODS IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 23 ASIA-PACIFIC VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 24 ASIA-PACIFIC REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 25 ASIA-PACIFIC REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 26 ASIA-PACIFIC CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 27 ASIA-PACIFIC LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 28 ASIA-PACIFIC NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 29 ASIA-PACIFIC CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 30 ASIA-PACIFIC NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 31 ASIA-PACIFIC KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 32 ASIA-PACIFIC INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 33 ASIA-PACIFIC INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 34 ASIA-PACIFIC ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 35 ASIA-PACIFIC SOFTWARE BY INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 36 NORTH AMERICA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
TABLE 37 ASIA-PACIFIC MAMMALIAN CELLS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 38 ASIA-PACIFIC PLANTS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 ASIA-PACIFIC FUNGI IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 40 ASIA-PACIFIC VIRUS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 41 ASIA-PACIFIC BACTERIA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 42 ASIA-PACIFIC TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
TABLE 43 ASIA-PACIFIC PLASMID DNA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 44 ASIA-PACIFIC BACTERIA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 45 ASIA-PACIFIC PROTEINS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 46 ASIA-PACIFIC DNA OLIGONUCLEOTIDES IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 47 ASIA-PACIFIC RIBONUCLEOPROTEIN COMPLEXES (RNPS) IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 48 ASIA-PACIFIC BACTERIA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 49 ASIA-PACIFICTRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 50 ASIA-PACIFIC IN VITRO APPLICATION IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 51 NORTH AMERICA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 52 ASIA-PACIFIC IN VIVO APPLICATION IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 53 NORTH AMERICA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 54 ASIA-PACIFIC BIOPRODUCTION IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 55 NORTH AMERICA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 56 ASIA-PACIFIC OTHERS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 57 ASIA-PACIFIC TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 58 ASIA-PACIFIC SYNTHETIC BIOLOGY IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 59 NORTH AMERICA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 60 ASIA-PACIFIC AGRICULTURE IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 61 ASIA-PACIFIC OTHERS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 62 NORTH AMERICA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 63 ASIA-PACIFIC RESEARCH IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 64 ASIA-PACIFIC PRE-CLINICAL IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 65 ASIA-PACIFIC CLINICAL PHASES IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 66 ASIA-PACIFIC COMMERCIAL IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 67 NORTH AMERICA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 68 ASIA-PACIFIC BIOPHARMA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 69 ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS (CROS) IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 70 ASIA-PACIFIC CONTRACT MANUFACTURING ORGANIZATION/ CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CMOS/CDMOS) IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 71 ASIA-PACIFIC ACADEMIA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 72 ASIA-PACIFIC HOSPITALS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 73 ASIA-PACIFIC CLINICAL LABS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 74 ASIA-PACIFIC OTHERS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 75 NORTH AMERICA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 76 ASIA-PACIFIC DIRECT TENDER IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 77 ASIA-PACIFIC RETAIL SALES IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 78 ASIA-PACIFIC OTHERS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 79 ASIA- PACIFIC TRANSFECTION MARKET, BY REGION, 2018-2028 (USD MILLION)
TABLE 80 ASIA-PACIFIC TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 81 ASIA-PACIFIC TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 82 ASIA-PACIFIC TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 83 ASIA-PACIFIC STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 84 ASIA-PACIFIC STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 85 ASIA-PACIFIC TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 86 ASIA-PACIFIC NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 87 ASIA-PACIFIC CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 88 ASIA-PACIFIC PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 89 ASIA-PACIFIC VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 90 ASIA-PACIFIC CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 91 ASIA-PACIFIC NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 92 ASIA-PACIFIC CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 93 ASIA-PACIFIC PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 94 ASIA-PACIFIC VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 95 ASIA-PACIFIC TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 96 ASIA-PACIFIC REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 97 ASIA-PACIFIC CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 98 ASIA-PACIFIC LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 99 ASIA-PACIFIC NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 100 ASIA-PACIFIC CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 101 ASIA-PACIFIC KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 102 ASIA-PACIFIC NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 103 ASIA-PACIFIC INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 104 ASIA-PACIFIC INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
TABLE 105 ASIA-PACIFIC ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 106 ASIA-PACIFIC TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
TABLE 107 ASIA-PACIFIC TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
TABLE 108 ASIA-PACIFICTRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 109 ASIA-PACIFIC IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 110 ASIA-PACIFIC IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 111 ASIA-PACIFIC BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 112 ASIA-PACIFIC TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 113 ASIA-PACIFIC SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 114 ASIA-PACIFIC TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 115 ASIA-PACIFIC TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 116 ASIA-PACIFIC TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 117 CHINA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 118 CHINA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 119 CHINA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 120 CHINA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 121 CHINA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 122 CHINA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 123 CHINA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 124 CHINA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 125 CHINA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 126 CHINA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 127 CHINA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 128 CHINA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 129 CHINA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 130 CHINA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 131 CHINA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 132 CHINA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 133 CHINA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 134 CHINA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 135 CHINA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 136 CHINA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 137 CHINA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 138 CHINA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 139 CHINA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 140 CHINA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 141 CHINA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
TABLE 142 CHINA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 143 CHINA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
TABLE 144 CHINA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
TABLE 145 CHINA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 146 CHINA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 147 CHINA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 148 CHINA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 149 CHINA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 150 CHINA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 151 CHINA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 152 CHINA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 153 CHINA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 154 JAPAN TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 155 JAPAN TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 156 JAPAN TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 157 JAPAN STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 158 JAPAN STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 159 JAPAN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 160 JAPAN NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 161 JAPAN CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 162 JAPAN PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 163 JAPAN VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 164 JAPAN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 165 JAPAN NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 166 JAPAN CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 167 JAPAN PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 168 JAPAN VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 169 JAPAN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 170 JAPAN REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 171 JAPAN CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 172 JAPAN LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 173 JAPAN NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 174 JAPAN CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 175 JAPAN KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 176 JAPAN NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 177 JAPAN INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 178 JAPAN INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
TABLE 179 JAPAN ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 180 JAPAN TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
TABLE 181 JAPAN TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
TABLE 182 JAPAN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 183 JAPAN IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 184 JAPAN IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 185 JAPAN BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 186 JAPAN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 187 JAPAN SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 188 JAPAN TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 189 JAPAN TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 190 JAPAN TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 191 INDIA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 192 INDIA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 193 INDIA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 194 INDIA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 195 INDIA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 196 INDIA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 197 INDIA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 198 INDIA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 199 INDIA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 200 INDIA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 201 INDIA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 202 INDIA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 203 INDIA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 204 INDIA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 205 INDIA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 206 INDIA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 207 INDIA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 208 INDIA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 209 INDIA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 210 INDIA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 211 INDIA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 212 INDIA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 213 INDIA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 214 INDIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 215 INDIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
TABLE 216 INDIA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 217 INDIA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
TABLE 218 INDIA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
TABLE 219 INDIA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 220 INDIA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 221 INDIA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 222 INDIA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 223 INDIA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 224 INDIA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 225 INDIA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 226 INDIA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 227 INDIA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 228 AUSTRALIA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 229 AUSTRALIA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 230 AUSTRALIA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 231 AUSTRALIA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 232 AUSTRALIA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 233 AUSTRALIA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 234 AUSTRALIA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 235 AUSTRALIA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 236 AUSTRALIA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 237 AUSTRALIA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 238 AUSTRALIA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 239 AUSTRALIA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 240 AUSTRALIA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 241 AUSTRALIA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 242 AUSTRALIA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 243 AUSTRALIA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 244 AUSTRALIA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 245 AUSTRALIA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 246 AUSTRALIA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 247 AUSTRALIA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 248 AUSTRALIA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 249 AUSTRALIA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 250 AUSTRALIA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 251 AUSTRALIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 252 AUSTRALIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
TABLE 253 AUSTRALIA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 254 AUSTRALIA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
TABLE 255 AUSTRALIA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
TABLE 256 AUSTRALIA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 257 AUSTRALIA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 258 AUSTRALIA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 259 AUSTRALIA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 260 AUSTRALIA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 261 AUSTRALIA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 262 AUSTRALIA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 263 AUSTRALIA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 264 AUSTRALIA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 265 SOUTH KOREA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 266 SOUTH KOREA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 267 SOUTH KOREA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 268 SOUTH KOREA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 269 SOUTH KOREA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 270 SOUTH KOREA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 271 SOUTH KOREA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 272 SOUTH KOREA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 273 SOUTH KOREA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 274 SOUTH KOREA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 275 SOUTH KOREA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 276 SOUTH KOREA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 277 SOUTH KOREA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 278 SOUTH KOREA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 279 SOUTH KOREA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 280 SOUTH KOREA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 281 SOUTH KOREA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 282 SOUTH KOREA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 283 SOUTH KOREA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 284 SOUTH KOREA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 285 SOUTH KOREA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 286 SOUTH KOREA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 287 SOUTH KOREA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 288 SOUTH KOREA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 289 SOUTH KOREA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
TABLE 290 SOUTH KOREA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 291 SOUTH KOREA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
TABLE 292 SOUTH KOREA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
TABLE 293 SOUTH KOREA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 294 SOUTH KOREA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 295 SOUTH KOREA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 296 SOUTH KOREA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 297 SOUTH KOREA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 298 SOUTH KOREA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 299 SOUTH KOREA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 300 SOUTH KOREA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 301 SOUTH KOREA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 302 SINGAPORE TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 303 SINGAPORE TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 304 SINGAPORE TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 305 SINGAPORE STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 306 SINGAPORE STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 307 SINGAPORE TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 308 SINGAPORE NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 309 SINGAPORE CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 310 SINGAPORE PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 311 SINGAPORE VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 312 SINGAPORE CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 313 SINGAPORE NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 314 SINGAPORE CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 315 SINGAPORE PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 316 SINGAPORE VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 317 SINGAPORE TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 318 SINGAPORE REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 319 SINGAPORE CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 320 SINGAPORE LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 321 SINGAPORE NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 322 SINGAPORE CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 323 SINGAPORE KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 324 SINGAPORE NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 325 SINGAPORE INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 326 SINGAPORE INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
TABLE 327 SINGAPORE ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 328 SINGAPORE TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
TABLE 329 SINGAPORE TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
TABLE 330 SINGAPORE TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 331 SINGAPORE IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 332 SINGAPORE IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 333 SINGAPORE BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 334 SINGAPORE TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 335 SINGAPORE SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 336 SINGAPORE TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 337 SINGAPORE TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 338 SINGAPORE TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 339 THAILAND TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 340 THAILAND TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 341 THAILAND TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 342 THAILAND STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 343 THAILAND STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 344 THAILAND TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 345 THAILAND NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 346 THAILAND CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 347 THAILAND PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 348 THAILAND VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 349 THAILAND CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 350 THAILAND NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 351 THAILAND CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 352 THAILAND PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 353 THAILAND VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 354 THAILAND TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 355 THAILAND REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 356 THAILAND CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 357 THAILAND LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 358 THAILAND NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 359 THAILAND CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 360 THAILAND KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 361 THAILAND NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 362 THAILAND INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 363 THAILAND INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
TABLE 364 THAILAND ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 365 THAILAND TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
TABLE 366 THAILAND TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
TABLE 367 THAILAND TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 368 THAILAND IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 369 THAILAND IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 370 THAILAND BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 371 THAILAND TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 372 THAILAND SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 373 THAILAND TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 374 THAILAND TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 375 THAILAND TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 376 MALAYSIA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 377 MALAYSIA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 378 MALAYSIA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 379 MALAYSIA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 380 MALAYSIA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 381 MALAYSIA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 382 MALAYSIA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 383 MALAYSIA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 384 MALAYSIA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 385 MALAYSIA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 386 MALAYSIA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 387 MALAYSIA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 388 MALAYSIA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 389 MALAYSIA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 390 MALAYSIA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 391 MALAYSIA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 392 MALAYSIA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 393 MALAYSIA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 394 MALAYSIA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 395 MALAYSIA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 396 MALAYSIA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 397 MALAYSIA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 398 MALAYSIA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 399 MALAYSIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 400 MALAYSIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
TABLE 401 MALAYSIA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 402 MALAYSIA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
TABLE 403 MALAYSIA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
TABLE 404 MALAYSIA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 405 MALAYSIA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 406 MALAYSIA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 407 MALAYSIA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 408 MALAYSIA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 409 MALAYSIA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 410 MALAYSIA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 411 MALAYSIA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 412 MALAYSIA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 413 MALAYSIA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 414 INDONESIA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 415 INDONESIA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 416 INDONESIA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 417 INDONESIA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 418 INDONESIA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 419 INDONESIA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 420 INDONESIA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 421 INDONESIA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 422 INDONESIA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 423 INDONESIA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 424 INDONESIA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 425 INDONESIA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 426 INDONESIA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 427 INDONESIA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 428 INDONESIA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 429 INDONESIA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 430 INDONESIA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 431 INDONESIA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 432 INDONESIA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 433 INDONESIA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 434 INDONESIA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 435 INDONESIA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 436 INDONESIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 437 INDONESIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
TABLE 438 INDONESIA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 439 INDONESIA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
TABLE 440 INDONESIA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
TABLE 441 INDONESIA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 442 INDONESIA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 443 INDONESIA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 444 INDONESIA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 445 INDONESIA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 446 INDONESIA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 447 INDONESIA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 448 INDONESIA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 449 INDONESIA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 450 PHILIPPINES TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 451 PHILIPPINES TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 452 PHILIPPINES TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 453 PHILIPPINES STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 454 PHILIPPINES STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 455 PHILIPPINES TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 456 PHILIPPINES NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 457 PHILIPPINES CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 458 PHILIPPINES PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 459 PHILIPPINES VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 460 PHILIPPINES CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 461 PHILIPPINES NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 462 PHILIPPINES CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 463 PHILIPPINES PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 464 PHILIPPINES VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 465 PHILIPPINES TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 466 PHILIPPINES REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 467 PHILIPPINES CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 468 PHILIPPINES LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 469 PHILIPPINES NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 470 PHILIPPINES CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 471 PHILIPPINES KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 472 PHILIPPINES NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 473 PHILIPPINES INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 474 PHILIPPINES INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
TABLE 475 PHILIPPINES ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 476 PHILIPPINES TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
TABLE 477 PHILIPPINES TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
TABLE 478 PHILIPPINES TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 479 PHILIPPINES IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 480 PHILIPPINES IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 481 PHILIPPINES BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 482 PHILIPPINES TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 483 PHILIPPINES SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 484 PHILIPPINES TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 485 PHILIPPINES TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 486 PHILIPPINES TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 487 REST OF ASIA- PACIFIC TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
Abbildungsverzeichnis
LIST OF FIGURES
FIGURE 1 ASIA-PACIFIC TRANSFECTION MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC TRANSFECTION MARKET : DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC TRANSFECTION MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC TRANSFECTION MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC TRANSFECTION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC TRANSFECTION MARKET: MULTIVARIATE MODELLING
FIGURE 7 ASIA-PACIFIC TRANSFECTION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 ASIA-PACIFIC TRANSFECTION MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA-PACIFIC TRANSFECTION MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 ASIA-PACIFIC TRANSFECTION MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 ASIA-PACIFIC TRANSFECTION MARKET: SEGMENTATION
FIGURE 12 INCREASING OCCURENCE OF CHRONIC DISEASES AND DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS IS DRIVING THE ASIA-PACIFIC TRANSFECTION MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 TRANSIENT TRANSFECTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC TRANSFECTION MARKET IN 2021 & 2028
FIGURE 14 APPROVAL PROCESS FOR GENE THERAPY IN CHINA
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC TRANSFECTION MARKET
FIGURE 16 ASIA-PACIFIC TRANSFECTION MARKET: BY TYPE, 2020
FIGURE 17 ASIA-PACIFIC TRANSFECTION MARKET: BY TYPE, 2020-2028 (USD MILLION)
FIGURE 18 ASIA-PACIFIC TRANSFECTION MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 19 ASIA-PACIFIC TRANSFECTION MARKET: BY TYPE, LIFELINE CURVE
FIGURE 20 ASIA-PACIFIC TRANSFECTION MARKET: BY METHODS, 2020
FIGURE 21 ASIA-PACIFIC TRANSFECTION MARKET: BY METHODS, 2020-2028 (USD MILLION)
FIGURE 22 ASIA-PACIFIC TRANSFECTION MARKET: BY METHODS, CAGR (2021-2028)
FIGURE 23 ASIA-PACIFIC TRANSFECTION MARKET: BY METHODS, LIFELINE CURVE
FIGURE 24 ASIA-PACIFIC TRANSFECTION MARKET: BY METHODS, 2020
FIGURE 25 ASIA-PACIFIC TRANSFECTION MARKET: BY METHODS, 2020-2028 (USD MILLION)
FIGURE 26 ASIA-PACIFIC TRANSFECTION MARKET: BY METHODS, CAGR (2021-2028)
FIGURE 27 ASIA-PACIFIC TRANSFECTION MARKET: BY METHODS, LIFELINE CURVE
FIGURE 28 ASIA-PACIFIC TRANSFECTION MARKET: BY PRODUCT, 2020
FIGURE 29 ASIA-PACIFIC TRANSFECTION MARKET: BY PRODUCT, 2020-2028 (USD MILLION)
FIGURE 30 ASIA-PACIFIC TRANSFECTION MARKET: BY PRODUCT, CAGR (2021-2028)
FIGURE 31 ASIA-PACIFIC TRANSFECTION MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 32 ASIA-PACIFIC TRANSFECTION MARKET: BY ORGANISM, 2020
FIGURE 33 ASIA-PACIFIC TRANSFECTION MARKET: BY ORGANISM, 2020-2028 (USD MILLION)
FIGURE 34 ASIA-PACIFIC TRANSFECTION MARKET: BY ORGANISM, CAGR (2021-2028)
FIGURE 35 ASIA-PACIFIC TRANSFECTION MARKET: BY ORGANISM, LIFELINE CURVE
FIGURE 36 ASIA-PACIFIC TRANSFECTION MARKET: BY TYPES OF MOLECULE, 2020
FIGURE 37 ASIA-PACIFIC TRANSFECTION MARKET: BY TYPES OF MOLECULE, 2020-2028 (USD MILLION)
FIGURE 38 ASIA-PACIFIC TRANSFECTION MARKET: BY TYPES OF MOLECULE, CAGR (2021-2028)
FIGURE 39 ASIA-PACIFIC TRANSFECTION MARKET: BY TYPES OF MOLECULE LIFELINE CURVE
FIGURE 40 ASIA-PACIFIC TRANSFECTION MARKET: BY APPLICATION, 2020
FIGURE 41 ASIA-PACIFIC TRANSFECTION MARKET: BY APPLICATION, 2020-2028 (USD MILLION)
FIGURE 42 ASIA-PACIFIC TRANSFECTION MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 43 ASIA-PACIFIC TRANSFECTION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 44 ASIA-PACIFIC TRANSFECTION MARKET: BY STAGES, 2020
FIGURE 45 ASIA-PACIFIC TRANSFECTION MARKET: BY STAGES, 2020-2028 (USD MILLION)
FIGURE 46 ASIA-PACIFIC TRANSFECTION MARKET: BY STAGES, CAGR (2021-2028)
FIGURE 47 ASIA-PACIFIC TRANSFECTION MARKET: BY STAGES, LIFELINE CURVE
FIGURE 48 ASIA-PACIFIC TRANSFECTION MARKET: BY END USER, 2020
FIGURE 49 ASIA-PACIFIC TRANSFECTION MARKET: BY END USER, 2020-2028 (USD MILLION)
FIGURE 50 ASIA-PACIFIC TRANSFECTION MARKET: BY END USER, CAGR (2021-2028)
FIGURE 51 ASIA-PACIFIC TRANSFECTION MARKET: BY END USER, LIFELINE CURVE
FIGURE 52 ASIA-PACIFIC TRANSFECTION MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 53 ASIA-PACIFIC TRANSFECTION MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)
FIGURE 54 ASIA-PACIFIC TRANSFECTION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 55 ASIA-PACIFIC TRANSFECTION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 56 ASIA-PACIFIC TRANSFECTION MARKET: SNAPSHOT (2020)
FIGURE 57 ASIA-PACIFIC TRANSFECTION MARKET: BY COUNTRY (2020)
FIGURE 58 ASIA-PACIFIC TRANSFECTION MARKET: BY COUNTRY (2021 & 2028)
FIGURE 59 ASIA-PACIFIC TRANSFECTION MARKET: BY COUNTRY (2020 & 2028)
FIGURE 60 ASIA-PACIFIC TRANSFECTION MARKET: BY TYPE (2021-2028)
FIGURE 1 ASIA-PACIFIC TRANSFECTION MARKET: COMPANY SHARE 2020 (%)
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
